NETosis in tumour microenvironment of liver: From primary to metastatic hepatic carcinoma
Yi Yang,
No information about this author
Siyue Yu,
No information about this author
Chao Lv
No information about this author
et al.
Ageing Research Reviews,
Journal Year:
2024,
Volume and Issue:
97, P. 102297 - 102297
Published: April 9, 2024
Language: Английский
Applications of gene pair methods in clinical research: advancing precision medicine
Molecular Biomedicine,
Journal Year:
2025,
Volume and Issue:
6(1)
Published: April 9, 2025
Abstract
The
rapid
evolution
of
high-throughput
sequencing
technologies
has
revolutionized
biomedical
research,
producing
vast
amounts
gene
expression
data
that
hold
immense
potential
for
biological
discovery
and
clinical
applications.
Effectively
mining
these
large-scale,
high-dimensional
is
crucial
facilitating
disease
detection,
subtype
differentiation,
understanding
the
molecular
mechanisms
underlying
progression.
However,
conventional
paradigm
single-gene
profiling,
measuring
absolute
levels
individual
genes,
faces
critical
limitations
in
implementation.
These
include
vulnerability
to
batch
effects
platform-dependent
normalization
requirements.
In
contrast,
emerging
approaches
analyzing
relative
relationships
between
pairs
demonstrate
unique
advantages.
By
focusing
on
binary
comparisons
two
genes’
magnitudes,
methods
inherently
normalize
experimental
variations
while
capturing
biologically
stable
interaction
patterns.
this
review,
we
systematically
evaluate
pair-based
analytical
frameworks.
We
classify
eleven
computational
into
fundamental
categories:
value-based
quantifying
differential
patterns,
rank-based
exploiting
transcriptional
ordering
relationships.
To
bridge
methodological
development
with
practical
implementation,
establish
a
reproducible
pipeline
incorporating
feature
selection,
classifier
construction,
model
evaluation
modules
using
real-world
benchmark
datasets
from
pulmonary
tuberculosis
studies.
findings
position
pair
analysis
as
transformative
omics
data,
direct
implications
precision
biomarker
mechanistic
studies
Language: Английский
Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps
Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
15(9), P. 2678 - 2690
Published: Jan. 1, 2024
Background:
Prostate
adenocarcinoma
(PRAD)
is
one
of
the
most
common
cancers
in
male.Increasing
evidences
pointed
out
that
Neutrophil
Extracellular
Traps
(NETs)
play
an
important
role
tumor
angiogenesis,
metastasis
and
drug
resistance.However,
limited
systematic
studies
regarding
NETs
PRAD
have
been
performed.Identification
biomarkers
based
on
might
facilitate
risk
stratification
which
help
optimizing
clinical
strategies.Methods:
NETs-related
genes
with
differential
expressions
were
identified
between
adjacent
normal
tissues
TCGA-PRAD
dataset.Consensus
cluster
analysis
was
performed
to
determine
subtypes
different-expressed
genes.The
difference
pathway
enrichment,
infiltrating
immune
cell
genomic
mutation
also
evaluated
subtypes.LASSO
cox
regression
conducted
construct
a
prognostic
signature.Result:
We
19
related
tissue
dataset.Two
significant
these
by
consensus
analysis,
namely
subtype
1
2.
Significant
differences
prognosis,
infiltration
burden
observed
Cox
NETs-associated
signature
including
13
genes,
this
had
good
performance
predicting
progression-free
survival
patients.Further
integrated
indicated
MMP9
mostly
expressed
Mono/Macrophage
cells
regulating
formation
via
neutrophil
activation
PRAD.
Conclusion:To
sum
up,
current
study
two
molecular
constructed
for
Language: Английский
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
Shun Horaguchi,
No information about this author
Yoshiro Nakahara,
No information about this author
Yuka Igarashi
No information about this author
et al.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 1831 - 1831
Published: Aug. 12, 2024
Neutrophil
extracellular
traps
(NETs)
released
from
neutrophils
are
related
to
cancer
progression.
However,
the
relationship
between
therapeutic
effects
of
immune
checkpoint
inhibitors
(ICIs)
such
as
anti-PD-1
and
anti-PD-L1
antibodies
plasma
NET
concentration
in
patients
with
non-small
cell
lung
(NSCLC)
is
poorly
understood.
In
this
study,
concentrations
citrullinated
histone
H3
(CitH3),
a
surrogate
marker
NETs,
before/after
treatment
were
examined
advanced
or
recurrent
NSCLC
undergoing
ICI
(n
=
185).
The
clinical
significances
levels
posttreatment
changes
statistically
evaluated.
As
result,
multivariate
Cox
analysis
showed
that
high
before
significant
predictors
unfavorable
overall
survival
(OS;
Language: Английский